Efficacy and Safety Study of NV1FGF in Patients With Severe Peripheral Artery Occlusive Disease

NCT00368797 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

125

Enrollment

INDUSTRY

Sponsor class

Conditions

Peripheral Arterial Disease

Interventions

DRUG: XRP0038 (NV1FGF)

Sponsor

Sanofi